Josephs Paul bought LFCR

July 8, 2025 · Form 4 insider transaction

Josephs Paul bought 150,000 shares of Lifecore Biomedical, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
150,000
Price
N/A
Total value
N/A
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 8, 2025
Filing dateJuly 10, 2025
Shares owned after688,185
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone.; Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

View the original Form 4 on SEC EDGAR